CAS 1069-66-5
:Sodium valproate
Description:
Sodium valproate, with the CAS number 1069-66-5, is the sodium salt of valproic acid, a compound widely used in the treatment of epilepsy and bipolar disorder. It appears as a white to off-white crystalline powder and is highly soluble in water, which facilitates its administration in various pharmaceutical formulations. The substance acts primarily as an anticonvulsant and mood stabilizer, functioning by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, thereby exerting a calming effect on neuronal activity. Sodium valproate is typically administered orally, and its pharmacokinetics can be influenced by factors such as age, liver function, and concurrent medications. While generally well-tolerated, it may cause side effects, including gastrointestinal disturbances, weight gain, and, in rare cases, hepatotoxicity. Due to its potential teratogenic effects, careful consideration is necessary when prescribing to pregnant individuals. Overall, sodium valproate is a crucial therapeutic agent in managing certain neurological and psychiatric conditions.
Formula:C8H16O2·Na
InChI:InChI=1S/C8H16O2.Na/c1-3-5-7(6-4-2)8(9)10;/h7H,3-6H2,1-2H3,(H,9,10);
InChI key:InChIKey=RGZUPIWJTSGERU-UHFFFAOYSA-N
SMILES:C(CCC)(CCC)C(O)=O.[Na]
Synonyms:- Acediprol
- Convulex
- Depacon
- Depakene
- Depakene R
- Depakene syrup 8
- Depakin
- Depakine chronosphere
- Dipropylacetate sodium
- Encorate
- Epilim
- Kw 6066N
- Micropakine LP
- Natriumvalproat
- Orfiril
- Pentanoic acid, 2-propyl-, sodium salt (1:1)
- Selenica R
- Sodium 2-propylpentanoate
- Sodium 2-propylvalerate
- Sodium Valproate
- Sodium bispropylacetate
- Sodium dipropylacetate
- Sodium α,α-dipropylacetate
- Valeric acid, 2-propyl-, sodium salt
- Valerin
- Valproate De Sodium
- Valproate sodium
- Valproato De Sodio
- Valproic acid sodium salt
- Valpron
- Vupral
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 14 products.
Sodium Valproate
CAS:Formula:C8H15NaO2Purity:>98.0%(T)Color and Shape:White to Almost white powder to crystalMolecular weight:166.20SODIUM VALPROATE CRS
CAS:<p>SODIUM VALPROATE CRS</p>Formula:C8H15NaO2Color and Shape:PowderMolecular weight:166.1933Sodium valproate
CAS:Sodium valproateFormula:C8H15NaO2Purity:98.5%Color and Shape:White To Off WhiteMolecular weight:166.09697Sodium 2-Propylpentanoate
CAS:Formula:C8H15NaO2Purity:97%Color and Shape:SolidMolecular weight:166.1933Ref: IN-DA0035L9
5g24.00€10gTo inquire15gTo inquire25g43.00€50gTo inquire75gTo inquire100g79.00€500g178.00€Sodium valproate
CAS:Formula:C8H15NaO2Purity:(Titration) 98.5 - 101.0 % (dried basis)Color and Shape:White to almost white crystalline powderMolecular weight:166.19Valproic acid sodium salt
CAS:<p>Sodium valproate is an anti-epileptic, boosting brain GABA levels and possibly affecting potassium channels for membrane stability.</p>Formula:C8H15NaO2Purity:98.43% - 99.78%Color and Shape:White PowderMolecular weight:166.2Sodium valproate
CAS:<p>Sodium valproate</p>Formula:C8H15O2·NaPurity:98%Color and Shape: white powderMolecular weight:166.19g/molSodium Valproate
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Antiepileptic; increases levels of GABA in the brain.<br>References Chang, Z.L., et al.: Anal. Profiles Drug Subs., 8, 529 (1979), Nau, H., et al.: Pharmacol. Toxicol., 69, 310 (1991), Loscher, W., et al.: Prog. Neurobiol., 58, 31 (1999)<br></p>Formula:C8H15O2·NaColor and Shape:White Or Off WhiteMolecular weight:166.19Sodium valproate
CAS:Controlled Product<p>Sodium valproate is an anticonvulsant drug that has been used to treat bipolar disorder, epilepsy, and migraine headaches. It is a salt of valproic acid and sodium, with a molecular weight of 266.7. Sodium valproate is available in the form of capsules or tablets that are taken orally. This drug has been shown to have interactions with other drugs such as antibiotics, painkillers, and cholesterol-lowering medicines. Side effects include hypersensitivity syndrome, which may be due to an allergic reaction. Sodium valproate has also been linked to the development of blood clots in veins (thrombosis) and decreased white blood cells (leukopenia).<br>The side-effect profiles of sodium valproate are determined by the pharmacological treatment and dosage level in clinical trials. The efficacy of sodium valproate can be assessed by its ability to reduce seizure frequency or severity in patients with epilepsy when titrated calorimetry is used as the</p>Formula:C8H15NaO2Color and Shape:White PowderMolecular weight:166.19 g/mol













